Sunday, October 23, 2016

Zolpimist


Zolpimist is a brand name of zolpidem, approved by the FDA in the following formulation(s):


ZOLPIMIST (zolpidem tartrate - spray, metered; oral)



  • Manufacturer: NOVADEL

    Approval date: December 19, 2008

    Strength(s): 5MG/SPRAY [RLD]

Has a generic version of Zolpimist been approved?


No. There is currently no therapeutically equivalent version of Zolpimist available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Zolpimist. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Buccal, polar and non-polar spray containing zolpidem
    Patent 7,632,517
    Issued: December 15, 2009
    Inventor(s): Dugger, III; Harry A. & Abd El-Shafy; Mohammed
    Assignee(s): Novadel Pharma Inc.
    Buccal aerosol sprays or capsules using polar and non-polar solvents have now been developed which provide zolpidem for rapid absorption through the oral mucosa, resulting in fast onset of effect. The buccal polar compositions of the invention comprise formulation I: aqueous polar solvent, zolpidem, and optional flavoring agent; formulation II: aqueous polar solvent, zolpidem, optionally flavoring agent, and propellant; formulation III: non-polar solvent, zolpidem, and optional flavoring agent; formulation IV: non-polar solvent, zolpidem, optional flavoring agent, and propellant; formulation V: a mixture of a polar solvent and a non-polar solvent, zolpidem, and optional flavoring agent; formulation VI: a mixture of a polar solvent and a non-polar solvent, zolpidem, optional flavoring agent, and propellant.
    Patent expiration dates:

    • October 1, 2017
      ✓ 
      Patent use: TREATMENT OF TRANSIENT INSOMNIA



See also...

  • ZolpiMist Consumer Information (Drugs.com)
  • Zolpimist Oral Spray Consumer Information (Wolters Kluwer)
  • Zolpimist Consumer Information (Cerner Multum)
  • Zolpimist Advanced Consumer Information (Micromedex)
  • Zolpidem Consumer Information (Drugs.com)
  • Zolpidem Consumer Information (Wolters Kluwer)
  • Zolpidem Extended-Release Tablets Consumer Information (Wolters Kluwer)
  • Zolpidem Oral Spray Consumer Information (Wolters Kluwer)
  • Zolpidem Consumer Information (Cerner Multum)
  • Zolpidem Oral, Oromucosal Advanced Consumer Information (Micromedex)
  • Zolpidem Tartrate AHFS DI Monographs (ASHP)

No comments:

Post a Comment